← Evidence map

ArticleJournal of gastrointestinal oncology2024

Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function.

Takanori Masumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function. | OpenQuestion